Search Results - neuritogenesis

2 Results Sort By:
Use of fluorescent ANTS to examine the BBB-permeability of polysaccharide
Project ID: D2015-27Invention Description: Methods of generating and administering digestion products of FDA-approved low acyl gellan gum (LA-GAGR) to produce neuroprotective mega-GAGR, midi-GAGR, and mini-GAGR and administration thereof.Applications: Compositions comprising midi and/or mini-GAGR have been shown to be useful for treatment of neurodegenerative...
Published: 8/3/2022   |   Updated: 6/17/2015   |   Inventor(s): Joshua Park, Kevin Christopher, Vishruti Makani
Keywords(s): ALS, Alzheimer’s disease, Blood-brain Barrier, Brain Trauma, Neuritogenesis, Neurodegenerative, Neuroprotective, Spinal Cord Injury
Category(s):  
Novel agents and methods for treating neurodegenerative disorders
Project ID: D2013-69 Midi-GAGR has several desired properties (neurotrophic, anti-oxidant, non-cytotoxic, anti-inflammatory, and BBB-permeable) for treatment of neurodegenerative diseases. Such materials have been shown to cross the blood-brain barrier, reduce the degeneration of cortical, peripheral, and dopaminergic nerve cells under pathogenic...
Published: 4/15/2026   |   Updated: 6/17/2015   |   Inventor(s): Joshua Park, Dong Shik Kim, Kenneth Hensley
Keywords(s): ALS, Alzheimer’s disease, Blood-brain Barrier, Brain Trauma, Neuritogenesis, Neurodegenerative, Neuroprotective, Spinal, Spinal Cord Injury
Category(s): Neuroscience